Home | News | Directories | Calendar | Maps | Contact Us | Webmail
Perelman School of Medicine at the University of Pennsylvania Advanced Search

Nevena Damjanov, MD

Nevena Damjanov, MD

faculty photo
Associate Professor of Clinical Medicine
Department: Medicine

Contact information
Penn Presbyterian Medical Center
51 North 39th Street
103A MAB
Philadelphia, PA 19104
Office: 215-662-9154
Fax: 215-243-3249
Education:
BA (Biology, Philosophy)
University of Pennsylvania, 1985.
MD (Internal Medicine)
Hahnemann University, 1989.
Permanent link
 
Perelman School of Medicine > Faculty > Search

Selected Publications

Sun, W., Sohal, D., Mykulowycz, K., Teitelbaum, U.R., Damjanov, N., Giantonio, B.J., Carberry, M., Wissel, P., Jacobs-Small, M., O’Dwyer, P.J.: An interim evaluation of efficacy and safety of the combination of panitumumab, gemcitabine, and irinotecan in patients with advanced or metastatic cholangiocarcinoma: A phase II study. Journal of Clinical Oncology 30(328a), June 2012 Notes: Poster presentation and abstract.

Sinha S, Levine M, Damjanov N, Reddy KR, Olthoff K, Shaked A, Hoteit M: Hepato-Cholangiocarcinoma in Liver Transplantation: Frequency and Outcomes. American Journal of Transplantation 11 Suppl 2: 466-466, APR 2011 Notes: Meeting Abstract: 1501 (Poster presentation).

Hall, MJ, Egleston, B, Miller, SM, Buzaglo, JS, Millard, J, Ridgway, C, Damjanov, N, Sprandio, JD, Meropol, NJ: Barriers to participation in cancer prevention clinical trials. Acta Oncologica 49(6): 757-766, AUG 2010.

Ross, HJ, Blumenschein, GR, Aisner, J, Damjanov, N, Dowlati, A, Garst, J, Rigas, JR, Smylie, M, Hassani, H, Allen, KE, Leopold, L, Zaks, TZ, Shepherd, FA: Randomized Phase II Multicenter Trial of Two Schedules of Lapatinib as First- or Second-Line Monotherapy in Patients with Advanced or Metastatic Non-Small Cell Lung Cancer. Clinical Cancer Research 16(6): 1938-1949, MAR 15 2010.

Sun W, Mykulowycz K, Teitelbaum UR, Damjanov N, Haller DG, Giantonio BJ, Carberry M, O’Dwyer PJ: Panitumumab, gemcitabine, and irinotecan in patients with advanced or metastatic cholangiocarcinoma: A phase II study. Journal of Clinical Oncology 28(15s): suppl; abstr TPS214, 2010 Notes: Poster presentation

Damjanov N: Gastric Cancer. Core Content Review of Family Medicine 40(3): 57-59, 2009.

Damjanov, N, Weiss, J, Haller, DG: Resection of the Primary Colorectal Cancer Is Not Necessary in Nonobstructed Patients with Metastatic Disease. Oncologist 14(10): 963-969, 2009.

Damjanov, N: Commentary: Colonoscopic Findings and Tumor Site Do Not Predict Bowel Obstruction During Medical Treatment of Stage IV Colon Cancer. Oncologist 14(6): 578-579, 2009.

Fetterly, GJ, Grasela, TH, Sherman, JW, Dul, JL, Grahn, A, Lecomte, D, Fiedler-Kelly, J, Damjanov, N, Fishman, M, Kane, MP, Rubin, EH, Tan, AR: Pharmacokinetic/pharmacodynamic modeling and simulation of neutropenia during phase I development of liposome-entrapped paclitaxel. Clinical Cancer Research 14(18): 5856-5863, SEP 15 2008.

Grasela TH, Fetterly GJ, Dul JL, LeComte D, Grahn AY, Fiedler-Kelly JB, Sherman JW, Damjanov N, Fishman MN, Tan AR: Modeling and simulation of neutropenia to support dosing regimens for liposome-encapsulated paclitaxel easy-to-use (LEP- ETU). Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings (Post-Meeting Edition) 25(18S): 13011, JUN 20 Suppl 2007 Notes: Abstract only.

back to top
Last updated: 11/20/2014
The Trustees of the University of Pennsylvania